| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |